Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study
NCT ID: NCT02706340
Last Updated: 2018-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
309 participants
OBSERVATIONAL
2015-04-30
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Postpartum Intrauterine Device (IUD) Placement
NCT01594476
Early vs. Interval Postpartum IUD Insertion
NCT03462758
Patient Centered Postpartum Contraception App
NCT03402217
Assessment of Postpartum Education to Improve Compliance
NCT04486170
Optimizing Pregnancy and Treatment Interventions for Moms 2.0
NCT03833245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaginal delivery
Women who have had a copper IUD placed within 10 minutes of a vaginal delivery of at least 34 weeks 0 days gestation.
No intervention - observational study only
Cesarean delivery
Women who have had a copper IUD placed within 10 minutes of a cesarean delivery of at least 34 weeks 0 days gestation.
No intervention - observational study only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention - observational study only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant, 24 weeks 0 days gestation or more OR who have had a delivery at 34 weeks 0 days gestation or more
* Anticipating a delivery at the Hospital of the University of Pennsylvania
* Desiring an immediate postplacental TCu380A IUD, OR who have given birth and received an immediate postplacental TCu380A IUD
* Able and willing to give consent in English
* Willing to follow up 6 months after delivery
Exclusion Criteria
* Known cervical cancer or carcinoma in situ
* History of undiagnosed abnormal vaginal bleeding prior to pregnancy
* Unwilling to follow up in the six months following delivery will be excluded
* Preterm delivery (33 weeks 6 days gestation or less at birth)
* Clinical diagnosis of chorioamnionitis or treatment for presumed chorioamnionitis
* No longer desiring immediate postplacental TCu380A placement
* Subjects aged less than 18 years
* Men are excluded by the nature of this women's health research.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
822078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.